Multiple Drug Chemotheraphy Regimen for Patient with Hormonnally-Unresponsive carcinoma of the Prostate: A Preliminary Report
- 1 April 1977
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 117 (4), 467-471
- https://doi.org/10.1016/s0022-5347(17)58500-6
Abstract
Of 25 patients with estrogen-unresponsive prostatic adenocarcinoma submitted to multidrug chemotherapy, 6 had partial objective regression, 12 had objectively stable disease and 7 had progressive disease. The survival rates in the 3 groups were 63, 52 and 40 wk, respectively.This publication has 13 references indexed in Scilit:
- The Continued Evaluation of the Effects of Chemotherapy in Patients with Advanced Carcinoma of the ProstateJournal of Urology, 1976
- Chemotherapy of Advanced Prostatic Carcinoma with Cyclophosphamide or 5-Fluorouracil: Results of First National Randomized StudyJournal of Urology, 1975
- Chemotherapy of Thyroid Cancer with AdriamycinNew England Journal of Medicine, 1974
- Current Status of Bilateral Adrenalectomy or Advanced Prostatic CarcinomaAnnals of Surgery, 1974
- Non-hormonal cytotoxic agents in the treatment of prostatic adenocarcinomaCancer, 1973
- Adrenalectomy and hypophysectomy for prostatic cancerUrology, 1973
- Bilateral Adrenalectomy for Advanced Prostatic CarcinomaJournal of Urology, 1972
- Treatment for Multiple MyelomaJAMA, 1969
- SOME COMMENTS ON THE LONG-TERM RESULTS OF ENDOCRINE TREATMENT OF PROSTATIC CANCER1British Journal of Urology, 1958
- RADICAL PERINEAL PROSTATECTOMY FOR CARCINOMAJAMA, 1954